Medley Stock

Medley EBIT per Share

The EBIT per Share of Medley (4480.T) as of Aug 21, 2026 is 67.19 JPY. In the previous year, EBIT per Share was 71.18 JPY — a change of -5.60% (lower).

EBIT per Share

67.19JPY

YoY

-5.60%

Last updated:

EBIT per Share of Medley is 2026 67.19 JPY. EBIT per Share of Medley was 2025 71.18 JPY. It decreases by -5.60% lower compared to the previous year.
Access this data via the Eulerpool API

Medley Stock analysis

What does Medley do? Medley Inc is a global company specializing in the production and sale of pharmaceutical products. The company was founded in 1985 as a small business and has since become a leading player in the pharmaceutical industry, operating in over 150 countries. Medley Inc produces a variety of products in different areas such as cardiology, gastroenterology, oncology, orthopedics, neurology, and dermatology. The company's business model is based on the development and sale of generic products, which are imitation products of patented drugs. Medley Inc focuses on producing high-quality and effective medicines at competitive prices. The company has production sites in various countries to meet the demand for drugs in each region. In addition to being a manufacturer of medicines, Medley Inc also offers services such as drug distribution, clinical studies, research and development, consulting for pharmaceutical manufacturers, and customer training. The company places great importance on the quality and safety of its products and services and has implemented a comprehensive quality management system to meet its high standards. The product range of Medley Inc includes a variety of drugs used in different indications, including well-known drugs such as Tamoxifen for cancer, Fluoxetine for depression, Oxycodone for pain relief, and Levofloxacin as an antibiotic. Medley Inc strives to make affordable medications accessible to all people and works to improve healthcare worldwide. The company has formed long-term partnerships with organizations and governments in emerging countries to enhance access to affordable medicines. Overall, Medley Inc is a significant player in the pharmaceutical industry, focusing on the production of generics and improving healthcare globally. Through its efforts in quality, innovation, and partnerships, the company aims to have a positive impact on society. Medley is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medley stock

EBIT per Share of Medley is 67.19 JPY in 2026.

EBIT per Share of Medley changed from 71.18 JPY to 67.19 JPY, representing a -5.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Medley since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

Income Statement — Medley

All Key Metrics — Medley